Penthrox approved in Iceland
22 January 2018
ASX Announcement
Penthrox approved in Iceland
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Iceland.
The Icelandic Medicines Agency issued the Marketing Authorisation on 16 January 2018 making Penthrox available for sale effective immediately.
For the full announcement, please refer to the following link – ASX Announcement – Penthrox Approval in Iceland